Home
University of Bergen

Centre for Cancer Biomarkers CCBIO

Collage of photos from CCBIO situations; research, teaching, symposia.

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO's principal investigators:

honorary doctorate
Showing a full audience.

Full house for the Honorary Doctor Bruce R. Zetter

October 15th, Professor Bruce R. Zetter from Harvard Medical School and Boston Children’s Hospital was appointed as Honorary Doctor at the University of Bergen, Faculty of Medicine. The day before, October 14th, he gave his honorary doctor lecture, on the topic "RNA as a tool for cancer therapy...

SCANPATH 2019
Lars Akslen on stage in front of the audience

Nordic updates and networking in translational pathology

CCBIO hosted the 4th Annual Scandinavian Seminar on Translational Pathology at Solstrand Hotel, Os (Bergen), with 78 dedicated participants from Norway, Sweden and Finland.

News
The board at the stage, opening the workshop.

Oral pathology & oral cancer collaboration project with Eurasia countries received funding for two more years

In 2016 CCBIO’s Associate Investigator Professor Daniela Elena Costea received 3 million NOK in funding from the Norwegian Agency for International Cooperation and Quality Enhancement in Higher Education (https://diku.no/en) for a 3 year collaboration project for education and research in oral...

Nyhet
Group photo.

Harvard Medical School inspiration and award

CCBIO Associate Researcher Agnete S.T. Engelsen has just completed a one-year certificate program at Harvard Medical School (HMS), the High-Impact Cancer Research (HICR): Cancer, Biology and Therapeutics Program. Engelsen was the first attendee from Norway in this diverse group of highly motivated...

CCBIO/Harvard INTPART collaboration
Gigantic waterfall at Iceland, and people walking into a view plateau in the middle of it.

Stimulating scientific eruptions

Iceland’s dramatic landscape served as backdrop for generating ideas and action plans for new collaborations between the University of Bergen/CCBIO and Harvard Medical School/Vascular Biology Program in a meeting August 29th to September 3rd.

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.